Skip to content
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Menu
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Menu
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Publication Details
AFRICAN RESEARCH NEXUS
SHINING A SPOTLIGHT ON AFRICAN RESEARCH
Serum methylarginines and incident depression in a cohort of older adults
Journal of Affective Disorders, Volume 151, No. 2, Year 2013
Notification
URL copied to clipboard!
Description
Background Methylarginines are endogenous nitric oxide synthase inhibitors that have been implicated in depression. This study measured serum concentrations of l-arginine, asymmetric (ADMA) and symmetric (SDMA) dimethylarginine in a representative sample of older community-dwelling adults and determined their association with incident depression over 6-years of follow-up. Methods Data on clinical, lifestyle, and demographic characteristics, methylated arginines, and l-arginine (measured using LC-MS/MS) were collected from a population-based sample of older Australian adults (Median age=64 years; IQR=60-70) from the Hunter Community Study. Clinical depression was defined as a Centre for Epidemiological Studies Depression Scale (CES-D) score ≥16 or use of antidepressant medications. Results In adjusted analyses ADMA (Q3), SDMA (Q2), l-arginine (Q2), gender, and asthma remained statistically significant predictors of incident depression at follow-up. Quartile 3 of ADMA concentration was associated with 3.5 times the odds of developing depression compared with Q1 (OR=3.54; 95% CI: 1.25-9.99). Limitations Limitations of our study include the use of a subjective self-reported questionnaire tool using a dichotomous cut-off, together with use of antidepressant medications, as proxies for clinical depression. Moreover, similarly to most population studies on methylated arginines, the measurement of ADMA and SDMA from blood does not necessarily reflect intracellular concentrations of these compounds. Finally, there were no measures of nitric oxide metabolites to determine if these levels were altered in the presence of elevated methylarginines and depression. Conclusions After adjusting for clinical, demographic, biochemical, and pharmacological confounders, higher serum ADMA was independently associated with incident depression at 6-years follow-up. © 2013 Elsevier B.V.
Authors & Co-Authors
McEvoy, Mark A.
Australia, Callaghan
University of Newcastle, College of Health, Medicine and Wellbeing
Agho, Kingsley Emwinyore
Australia, Penrith
Western Sydney University
Kelly, Brian J.
Australia, Callaghan
The University of Newcastle, Australia
Zinellu, Angelo
Italy, Sassari
Università Degli Studi Di Sassari
Attia, John Richard
Australia, Callaghan
University of Newcastle, College of Health, Medicine and Wellbeing
Australia, Newcastle
John Hunter Hospital
Statistics
Citations: 18
Authors: 5
Affiliations: 9
Identifiers
Doi:
10.1016/j.jad.2013.06.033
ISSN:
15732517
Research Areas
Mental Health
Study Design
Cross Sectional Study
Cohort Study